ketoconazole has been researched along with Orphan Diseases in 2 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Orphan Diseases: Rare diseases that have not been well studied.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Aslan Kayıran, M | 1 |
Erdemir, AV | 1 |
Dağdelen, D | 1 |
Cebeci, F | 1 |
Koçoğlu, E | 1 |
Gürel, MS | 1 |
Sedhom, R | 1 |
Hu, S | 1 |
Ohri, A | 1 |
Infantino, D | 1 |
Lubitz, S | 1 |
2 other studies available for ketoconazole and Orphan Diseases
Article | Year |
---|---|
A rare fungal infection of infants: a diffuse case of mucocutaneous candidiasis.
Topics: Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Vulvovaginal; Female; Humans; Infant, Newbor | 2020 |
Symptomatic Cushing's syndrome and hyperandrogenemia in a steroid cell ovarian neoplasm: a case report.
Topics: Aged; Antineoplastic Agents, Hormonal; Cushing Syndrome; Disease Progression; Fatal Outcome; Female; | 2016 |